Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria

International Journal of Antimicrobial Agents

Volumn 37, Issue 2, 2011, Pages 145-151

  Garvey, Mark I ^a   Rahman, M Mukhlesur ^b   Gibbons, Simon ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antibiotic resistance; Efflux pump inhibitor; Synergistic interactions

Indexed keywords

ANEMONE NEMOROSA EXTRACT; ANGELICA SINENSIS EXTRACT; ANTIINFECTIVE AGENT; APIUM GRAVEOLENS EXTRACT; ARTEMISIA ABROTANUM EXTRACT; ARTEMISITA ABROTANUM EXTRACT; ASCLEPIAS TUBEROSA EXTRACT; BOSWELLIA SERRATA EXTRACT; CATHA EDULIS EXTRACT; CENTELLA ASIATICA EXTRACT; CHLOROFORM; CINNAMOMUM AROMATICUM EXTRACT; CIPROFLOXACIN; COMMIPHORA MOLMOL EXTRACT; DAUCUS CAROTA EXTRACT; EPHEDRA FUNEREAL EXTRACT; FALCARINDIOL; GLYCYRRHIZA GLABRA EXTRACT; LEVISTICUM OFFICINALE EXTRACT; LINOLEIC ACID; MELISSA OFFICINALIS EXTRACT; OLEIC ACID; PAPAVER SOMNIFERUM EXTRACT; PIMPINELLA ANISUM EXTRACT; PLANT EXTRACT; PULMONARIA OFFICINALIS EXTRACT; SOUR ORANGE EXTRACT; THYMUS VULGARIS EXTRACT; TUSSILAGO FARFARA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANEMONE NEMOROSA; ANISE; ANTIBACTERIAL ACTIVITY; ARTEMISIA ABROTANUM; ARTICLE; ASCLEPIAS; ASCLEPIAS TUBEROSA; CARROT; CELERY; CINNAMOMUM AROMATICUM; COMMIPHORA; CONTROLLED STUDY; DRUG POTENTIATION; EPHEDRA; EPHEDRA FUNEREAL; GRAM NEGATIVE BACTERIUM; LEVISTICUM; LEVISTICUM OFFICINALE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAPAVER SOMNIFERUM; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULMONARIA; PULMONARIA OFFICINALIS; SALMONELLA TYPHIMURIUM; THYME; TUSSILAGO; TUSSILAGO FARFARA;

ANTI-BACTERIAL AGENTS; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT, ACTIVE; CIPROFLOXACIN; DRUG SYNERGISM; ENTEROBACTERIACEAE; FLUORESCENT DYES; HUMANS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; PLANTS, MEDICINAL; PSEUDOMONAS AERUGINOSA;

EID: 78751574059     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.10.027     Document Type: Article

References (41)

1. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, and L.B. Rice Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin Infect Dis 48 2009 1 12
2. D. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Suppl. 1 2009 i29 i36
3. P.C. Hseih, S.A. Siegel, B. Rogers, D. Davis, and K. Lewis Bacteria lacking a multidrug efflux pump: a sensitive tool for drug discovery Proc Natl Acad Sci U S A 95 1998 6602 6606
4. A.A. Neyfakh, V.E. Bidnenko, and L.B. Chen Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system Proc Natl Acad Sci U S A 88 1991 4781 4785
5. G. Tegos, F.R. Stermitz, O. Lemovskaya, and K. Lewis Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials Antimicrob Agents Chemother 10 2002 3133 3141
6. F.R. Stermitz, K.K. Cashman, K.M. Halligan, C. Morel, G.P. Tegos, and K. Lewis Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors Bioorg Med Chem Lett 13 2003 1915 1918
7. G. Belofsky, D. Percivill, K. Lewis, G.P. Tegos, and J. Ekart Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria J Nat Prod 67 2004 481 484
8. G. Belofsky, R. Carreno, K. Lewis, A. Ball, G. Casadei, and G.P. Tegos Metabolites of the 'smoke tree', Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus J Nat Prod 69 2006 261 264
9. L. Cherigo, R. Pereda-Miranda, M. Fragoso-Serrano, N. Jacobo-Herrera, G.W. Kaatz, and S. Gibbons Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides J Nat Prod 71 2008 1037 1045
10. A. Kumar, I.A. Khan, S. Koul, J.L. Koul, S.C. Taneja, and I. Ali Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus J Antimicrob Chemother 61 2008 1270 1276
11. A. Timmer, J. Günther, G. Rücker, E. Motschall, G. Antes, and W.V. Kern Pelargonium sidoides extract for acute respiratory tract infections Cochrane Database Syst Rev 3 2008 CD006323
12. T. Rüegg, A.I. Calderón, E.F. Queiroz, P.N. Solís, A. Marston, and F. Rivas 3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium J Ethnopharmacol 103 2006 461 467
13. I.K. Sawer, M.I. Berry, M.W. Brown, and J.L. Ford The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae J Appl Bacteriol 79 1995 314 321
14. L.J.V. Piddock Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria Clin Microbiol Rev 19 2006 382 402
15. C. Wray, and W.J. Sojka Experimental Salmonella typhimurium infection in calves Res Vet Sci 25 1978 139 143
16. A. Buckley, M.A. Webber, S. Cooles, L.P. Randall, R.M. La Ragione, and M.J. Woodward The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis Cell Microbiol 8 2006 847 856
17. J.M. Blair, R.M. La Ragione, M.J. Woodward, and L.J. Piddock The membrane fusion protein AcrA has a distinct role in antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium J Antimicrob Chemother 64 2009 965 972
18. B.J. Tindall, P.A. Grimont, G.M. Garrity, and J.P. Euzéby Nomenclature and taxonomy of the genus Salmonella Int J Syst Evol Microbiol 55 2005 521 524
19. K. Nishino, T. Latifi, and E.A. Groisman Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium Mol Microbiol 59 2006 126 141
20. L.J.V. Piddock, D.G. White, K. Gensberg, L. Pumbwe, and D.J. Griggs Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella typhimurium Antimicrob Agents Chemother 44 2000 3118 3121
21. D.J.V. Eaves, V. Ricci, and L.J.V. Piddock Expression of acrB, acrF, acrB, marA and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance Antimicrob Agents Chemother 48 2004 1145 1150
22. M.A. Webber, A.M. Bailey, J.M.A. Blair, E. Morgan, M.P. Stevens, and J.C. Hinton The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host J Bacteriol 191 2009 4276 4285
23. L.J.V. Piddock, D.J. Griggs, M.C. Hall, and Y.F. Jin Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients Antimicrob Agents Chemother 37 1993 662 666
24. D. Lechner, M. Stavri, M. Oluwatuyi, R. Pereda-Miranda, and S. Gibbons The anti-staphylococcal activity of Angelica dahurica (Bai Zhi) Phytochemistry 65 2004 331 335
25. M. Kaouadji, F. De Pachtere, C. Pouget, A.J. Chulia, and S. Lavaitte Three additional phthalide derivatives, an epoxymonomer and two dimers from Ligusticum wallichii rhizomes J Nat Prod 49 1986 872 877
26. M.E. Lund, D.J. Blazevic, and J.M. Matsen Rapid gentamicin bioassay using a multiple-antibiotic-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 4 1973 569 573
27. L.J.V. Piddock, M.I. Garvey, M.M. Rahman, and S. Gibbons Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria J Antimicrob Chemother 65 2010 1215 1223
28. J.M. Andrews Determination of minimum inhibitory concentrations J Antimicrob Chemother 48 Suppl. 1 2001 5 16 [J Antimicrob Chemother 2002;49:1049]
29. Andrews JM. Determination of minimum inhibitory concentrations. http://www.bsac.org.uk/susceptibility-testing/guide-to-antimicrobial- susceptibility-testing.cfm. BSAC; 2006 [accessed 23 November 2010].
30. G.M. Eliopoulos, and R. Moellering Antimicrobial combinations V. Lorian, Antibiotics in laboratory medicine 4th ed. 1996 Lippincott Williams and Wilkins Baltimore, MD 330
31. F.C. Odds, and Synergy antagonism, and what the chequerboard puts between them J Antimicrob Chemother 52 2003 1 3
32. N.G. Coldham, M.A. Webber, M.J. Woodward, and L.J. Piddock A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli J Antimicrob Chemother 65 2010 1655 1663
33. D. Newman, and G. Cragg Natural products as a source of new drugs over the last 25 years J Nat Prod 70 2007 461 477
34. A. Ankli, M. Heinrich, P. Bork, L. Wolfram, P. Bauerfeind, and R. Brun Yucatec Mayan medicinal plants: evaluation based on indigenous uses J Ethnopharmacol 79 2002 43 52
35. M. Stavri, and S. Gibbons The antimycobacterial constituents of dill (Anethum graveolens) Phytother Res 19 2005 938 941
36. A. Schinkovitz, M. Stavri, S. Gibbons, and F. Bucar Antimycobacterial polyacteylenes from Levisticum officinale Phytother Res 22 2008 681 684
37. S.C. Chou, M.C. Everngam, G. Sturtz, and J.J. Beck Antibacterial activity of components from Lomatium californicum Phytother Res 20 2006 153 156
38. D.L. Arnold, R.W. Jackson, N.R. Waterfield, and J.W. Mansfield Evolution of microbial virulence: the benefits of stress Trends Genet 23 2007 293 300
39. S.O. Stoitsova, Y. Braun, M.S. Ullrich, and H. Weingart Characterization of the RND-type multidrug efflux pump MexAB-OprM of the plant pathogen Pseudomonas syringae Appl Environ Microbiol 74 2008 3387 3393
40. V. Lorenzi, A. Muselli, F.A. Bernardini, L. Berti, J.M. Pags, and L. Amaral Geraniol restores antibiotic activities against multidrug-resistant isolates from Gram-negative species Antimicrob Agents Chemother 53 2009 2209 2211
41. A. Adonizio, S.M. Leal, F.M. Ausubel, and K. Mathee Attenuation of Pseudomonas aeruginosa virulence by medicinal plants in a Caenorhabditis elegans model system Antimicrob Agents Chemother 57 2008 809 813